Search research articles
Contact Us
Filters
Showing results (51-60 of 608) with videos related to
Page
of 61
Sort By:
Lancet (London, England)
|
April 1, 2023
Fitusiran in haemophilia: a breakthrough drug with many unknowns
Flora Peyvandi, Isabella Garagiola, Maria Abbattista
Seminars in Thrombosis and Hemostasis
|
July 27, 2013
Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management
Flora Peyvandi, Marzia Menegatti, Roberta Palla
Thrombosis and Haemostasis
|
August 17, 2016
Key insights to understand the immunogenicity of FVIII products
Jenny Goudemand, Flora Peyvandi, Sébastien Lacroix-Desmazes
Journal of Thrombosis and Haemostasis : JTH
|
January 26, 2023
Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists
Wolfgang Miesbach, Graham R Foster, Flora Peyvandi
Blood
|
February 26, 2015
Rare bleeding disorders: diagnosis and treatment
Roberta Palla, Flora Peyvandi, Amy D Shapiro
Research and Practice in Thrombosis and Haemostasis
|
December 26, 2025
von Willebrand disease combined with other hemostasis disorders: an overlooked clinical entity
Omid Seidizadeh, Pier Mannuccio Mannucci, Flora Peyvandi
Seminars in Thrombosis and Hemostasis
|
October 20, 2015
Assessment of clotting factor concentrates--pivotal studies and long-term requirements
H Marijke van den Berg, Flora Peyvandi
Internal and Emergency Medicine
|
July 29, 2023
Hemophilia patients: are they naturally anticoagulated?
Armando Tripodi, Pier Mannuccio Mannucci, Flora Peyvandi
Journal of Thrombosis and Haemostasis : JTH
|
January 26, 2021
Von Willebrand disease type 2N: An update
Omid Seidizadeh, Flora Peyvandi, Pier Mannuccio Mannucci
Haematologica
|
September 3, 2010
Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
Flora Peyvandi, Roberta Palla, Luca A Lotta
Page
of 61
Search research articles
Search
Showing results (51-60 of 608) with videos related to
Sort By:
Page
of 61
Lancet (London, England)
|
April 1, 2023
Fitusiran in haemophilia: a breakthrough drug with many unknowns
Flora Peyvandi, Isabella Garagiola, Maria Abbattista
Seminars in Thrombosis and Hemostasis
|
July 27, 2013
Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management
Flora Peyvandi, Marzia Menegatti, Roberta Palla
Thrombosis and Haemostasis
|
August 17, 2016
Key insights to understand the immunogenicity of FVIII products
Jenny Goudemand, Flora Peyvandi, Sébastien Lacroix-Desmazes
Journal of Thrombosis and Haemostasis : JTH
|
January 26, 2023
Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists
Wolfgang Miesbach, Graham R Foster, Flora Peyvandi
Blood
|
February 26, 2015
Rare bleeding disorders: diagnosis and treatment
Roberta Palla, Flora Peyvandi, Amy D Shapiro
Research and Practice in Thrombosis and Haemostasis
|
December 26, 2025
von Willebrand disease combined with other hemostasis disorders: an overlooked clinical entity
Omid Seidizadeh, Pier Mannuccio Mannucci, Flora Peyvandi
Seminars in Thrombosis and Hemostasis
|
October 20, 2015
Assessment of clotting factor concentrates--pivotal studies and long-term requirements
H Marijke van den Berg, Flora Peyvandi
Internal and Emergency Medicine
|
July 29, 2023
Hemophilia patients: are they naturally anticoagulated?
Armando Tripodi, Pier Mannuccio Mannucci, Flora Peyvandi
Journal of Thrombosis and Haemostasis : JTH
|
January 26, 2021
Von Willebrand disease type 2N: An update
Omid Seidizadeh, Flora Peyvandi, Pier Mannuccio Mannucci
Haematologica
|
September 3, 2010
Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura
Flora Peyvandi, Roberta Palla, Luca A Lotta
Page
of 61